Connor Clark & Lunn Investment Management Ltd. Makes New Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT)

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT) in the third quarter, Holdings Channel reports. The fund acquired 32,661 shares of the company’s stock, valued at approximately $366,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CLPT. Rinkey Investments bought a new position in shares of ClearPoint Neuro in the second quarter worth $307,000. Point72 Asia Singapore Pte. Ltd. bought a new position in ClearPoint Neuro in the 2nd quarter valued at about $175,000. Price T Rowe Associates Inc. MD raised its position in shares of ClearPoint Neuro by 7.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 24,867 shares of the company’s stock valued at $170,000 after buying an additional 1,813 shares in the last quarter. Squarepoint Ops LLC bought a new stake in shares of ClearPoint Neuro during the 2nd quarter worth approximately $549,000. Finally, Renaissance Technologies LLC boosted its position in shares of ClearPoint Neuro by 562.6% during the 2nd quarter. Renaissance Technologies LLC now owns 169,700 shares of the company’s stock worth $915,000 after acquiring an additional 144,088 shares in the last quarter. Institutional investors and hedge funds own 30.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital boosted their price objective on shares of ClearPoint Neuro from $11.00 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, August 27th.

ClearPoint Neuro Stock Up 2.1 %

ClearPoint Neuro stock opened at $12.37 on Friday. The stock has a market cap of $341.16 million, a PE ratio of -17.93 and a beta of 1.10. ClearPoint Neuro, Inc. has a 12-month low of $5.11 and a 12-month high of $14.13. The business’s 50-day moving average price is $11.90 and its two-hundred day moving average price is $9.40.

ClearPoint Neuro Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.